Annexon, Inc. ANNX
$4.51
▲ +0.21% 24H
About
Annexon, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for autoimmune, neurodegenerative, and ophthalmic diseases. The company advances a pipeline of product candidates designed to target the classical complement pathway, a key component of the immune system impli…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees93
TickerANNX
Statistics
Market Cap$733.7M
Revenue (TTM)$0
Net Income-$206.7M
Net Margin—
EPS$-1.34
P/E-3.52
P/S—
P/B3.73
EV/EBITDA-2.81
ROE-87.6%
Dividend Yield—
Price$4.51
Data: Twelve Data · Revenue = mcap / P/S